Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074711 · ClinicalTrials.gov registry record · Phase 2
Adding Phosphorus to Osteoporosis Drug Treatment
A Phase 2 study of Osteoporosis and Osteopenia, sponsored by Creighton University.
- Completed
- Registry status
- Phase 2
- Development phase
- 241
- Enrollment target
- 1
- Study location
NCT00074711 is a Phase 2 study of Osteoporosis and Osteopenia that has completed, run by Creighton University. The registered enrollment target is 241 participants, below the 1,543-participant average among 84 other Osteoporosis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00074711, a Phase 2 study of Osteoporosis and Osteopenia, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 241 participants
- Enrollment target
- 1
- Study location
Study Summary
Osteoporosis causes bones to weaken and break more easily. Calcium and phosphorus are two minerals that are essential for normal bone formation. Unfortunately, calcium salts commonly prescribed in anti-osteoporosis treatment bind phosphorus from food and restrict phosphorus available for bone building. Teriparatide is a drug that reduces the risk of fractures by increasing bone thickness and strength. Vitamin D is also necessary for strong bones and teeth. The purpose of this study is to evaluate the bone-building effectiveness of two calcium supplements, one with a source of phosphorus and one without, in combination with teriparatide and vitamin D in women with osteoporosis.
Conditions Studied
Interventions
- DRUG Calcium carbonate
- DRUG Calcium Phosphate
Study Locations (1)
Nebraska
- Creighton University Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00074711
The ClinicalTrials.gov registry entry for NCT00074711 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,543-participant average among 84 other Osteoporosis trials with a reported enrollment target (84% lower). The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 2 interventions - of which Calcium carbonate is the first listed.
NCT00074711 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT00074711 about?
NCT00074711 is a clinical study titled "Adding Phosphorus to Osteoporosis Drug Treatment". Osteoporosis causes bones to weaken and break more easily. Calcium and phosphorus are two minerals that are essential for normal bone formation. Unfortunately, calcium salts commonly prescribed in anti-osteoporosis treatment bind phosphorus from food and restrict phosphorus available for bone buildi...
What is the current status of trial NCT00074711?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 241 participants. The study started on 2004-08. Estimated completion is 2008-06.
What conditions does trial NCT00074711 study?
This clinical trial studies the following conditions: Osteoporosis, Osteopenia.
What interventions are being tested in trial NCT00074711?
The interventions under investigation include: Calcium carbonate (DRUG), Calcium Phosphate (DRUG).
Who is sponsoring clinical trial NCT00074711?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00074711 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
RECRUITING · Phase 2
-
Calcium and Bone Mass in Young Females
COMPLETED · Phase 2
-
Comparison Study of PTHrP and PTH to Treat Osteoporosis
COMPLETED · Phase 2
-
Hormone Replacement Therapy to Treat Turner Syndrome
COMPLETED · Phase 2
-
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
COMPLETED · Phase 2
-
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.